According to the idea that the same receptor might activate different signaling pathways in different tumor histotypes, in prostate cancer cells, LPA increases functional invadopodia formation through RhoA and NF-κB, controlling osteolytic metastases (Hwang et al., 2016). Here, RHOA is linked to neoplasm.